Premium
Induction of lymphokine‐activated killer and natural killer cell activities from cryopreserved lymphocytes
Author(s) -
Kawai H.,
Komiyama A.,
Katoh M.,
Yabuhara A.,
Miyagawa Y.,
Akabane T.
Publication year - 1988
Publication title -
transfusion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.045
H-Index - 132
eISSN - 1537-2995
pISSN - 0041-1132
DOI - 10.1046/j.1537-2995.1988.28689059025.x
Subject(s) - lymphokine activated killer cell , lymphokine , cytotoxicity , cytotoxic t cell , k562 cells , flow cytometry , natural killer cell , interleukin 2 , cryopreservation , biology , lymphocyte , immunology , interleukin 21 , interleukin 12 , microbiology and biotechnology , chemistry , immune system , t cell , in vitro , biochemistry , leukemia , embryo
Lymphokine‐activated killer (LAK) and natural killer (NK) cells were studied for their capacity to retain cytotoxicity after cryopreservation. LAK cells were generated by a 4‐day culture of lymphocytes with recombinant interleukin‐2 (rIL‐2). Cytotoxicity was measured by 51 Cr‐release assay at effector:target ratios of 10:1 to 80:1. Cryopreserved LAK cells retained 58.8 to 87.4 percent of cytotoxicity, as compared with that in fresh control cells. Cryopreserved NK cell activity against K562 and Molt‐4 targets was 45.7 to 67.9 percent of the respective values of the fresh control cells. The responsiveness of NK cells to polyinosinic‐polycytidilic acid (poly I:C), interferon‐α (IFN‐α), or rIL‐2 remained intact. Activated NK cell activity after poly I:C or IFN‐α stimulation and that after rIL‐2 were, respectively, comparable to and higher than the endogenous NK cell activity of the fresh cells. The composition of lymphocyte subsets as determined by flow cytometry using monoclonal antibodies did not change after cryopreservation, indicating that cellular loss of the given subsets did not occur during the procedure. The retention of substantial levels of cytotoxicity in cryopreserved LAK and NK cells may make them promising candidates as cytotoxic effector cells.